21 July 2020 — Global Research
On May 22, an “authoritative” peer reviewed “evaluation” of HCQ was published in The Lancet. The study was allegedly based on data analysis of 96,032 patients hospitalized with COVID-19 from 671 hospitals Worldwide. That database had been fabricated. The Lancet study was “Retracted”. The objective of that fake study, quoted by the media (as well as by Dr. Anthony Fauci) was to kill the Hydroxychloroquine (HCQ) cure on behalf of Big Pharma.
And now, as documented by Fox News, US medical doctors are being threatened by the State Medical Licensing Boards not to prescribe HCQ, an effective treatment for COVID.
“75,000 to 100,000 lives would be saved” if the ban on HCQ is lifted said Yale Professor of Epidemiology Dr. Harvey Risch (Interview below)
There is media blackout on HCQ. “So much corruption in the medical field when it comes to bureaucrats” says Laura Ingraham.
And guess who was involved in blocking the use of HCQ? Dr. Anthony Fauci, advisor to president Trump.
Dr. Fauci had earlier stated categorically that the use of HCQ had not been studied in relation to the coronavirus. “No proven drug”: “Not Enough Known”. . That’s a “False Statement”.
What Fauci failed to mention is that Chloroquine had been tested fifteen years ago by the CDC as a drug to be used against coronavirus infections. Chloroquine was used in 2002 and tested against SARS-1 coronavirus in a study under the auspices of the CDC published in 2005 in the peer reviewed Virology Journal. The main conclusion of the article was that: Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. It was used in the SARS-1 outbreak in 2002. It had the endorsement of the CDC.
The ban on HCQ was intended to promote a $1.6 Billion HHS Contract with Big Pharma’s Gilead Sciences Inc.
Dr. Anthony Fauci, head of the NIAID granted the “Greenlight” to Gilead Sciences Inc. based on the “preliminary” findings NIH-NIAID study (May 22) which he coordinated: Remdesivir for the Treatment of Covid-19 — Preliminary Report (NEJM).
Who will be able to afford Remdisivir? Ask Dr. Fauci.
500,000 doses of Remdesivir are envisaged at $3,200 per patient, namely $1.6 billion
For further details see:
By Prof Michel Chossudovsky, July 13, 2020